Screener
Tectonic Therapeutics TECX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest expense | (8) | (20) |
| Other expense | (113) | (32) |
| Total other income, net | 2,060 | 2,392 |
| Net loss | (25,241) | (15,906) |
| Other comprehensive loss: | ||
| Foreign currency translation adjustment | 37 | (7) |
| Comprehensive loss | $(25,204) | $(15,913) |
| Net loss per share, basic and diluted | $(1.34) | $(0.93) |
Item 1. Financial Statements.
FAQ
- What is Tectonic Therapeutics's net income?
- Tectonic Therapeutics (TECX) reported net income of -$25.24M in Q1 2026.
- How has Tectonic Therapeutics's net income changed year-over-year?
- Tectonic Therapeutics's net income decreased by 58.7% year-over-year, from -$15.91M to -$25.24M.
- What is the long-term trend for Tectonic Therapeutics's net income?
- Over 4 years (2021 to 2025), Tectonic Therapeutics's net income has grown at a -11.2% compound annual growth rate (CAGR), from -$119.13M to -$74.15M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Tectonic Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude